Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
British American Tobacco $600 million notes offering
The investment-grade notes are due 2032
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
MSCI investment in Evora Global
We advised MSCI on the investment
Gamida Cell $20 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
NewMed Energy proposed combination with Capricorn Energy
We are advising NewMed on the transaction
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
Pon sale of interest in Hiller to Littlejohn & Co.
We advised Pon on the transaction
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing